GlassScriptPhysician profile
Prabhakar Mithal
NPI 1497172951
$5,905.50
in general payments reported to CMS, 2019-2025
41 companies · $1,449 in 2025
The $1,449 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $301 · 2022: $993 · 2023: $1,590 · 2024: $1,573 · 2025: $1,449.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,577 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,576.91 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $843.06 | 2021-2025 | Lithovue, Spaceoar System, Axonics |
| Sumitomo Pharma America, INC. | $586.82 | 2023-2025 | Gemtesa, Orgovyx |
| Janssen Biotech, INC. | $562.38 | 2022-2025 | Erleada |
| Medtronic, INC. | $474.26 | 2022-2025 | Interstim, Altaviva |
| Pfizer INC. | $456.27 | 2021-2025 | |
| Astellas Pharma US INC | $292.76 | 2021-2025 | Xtandi, Padcev |
| Astrazeneca Pharmaceuticals LP | $284.55 | 2021-2025 | Lynparza, Imfinzi |
| Coloplast Corp | $260.24 | 2023-2025 | Titan, Speedicath |
| Bayer Healthcare Pharmaceuticals INC. | $243.40 | 2022-2025 | |
| Axonics, INC. | $219.30 | 2023-2024 | Axonics, Bulkamid |
| Endo Pharmaceuticals INC. | $157.54 | 2021-2023 | Aveed, Xiaflex |
| Urovant Sciences INC | $153.78 | 2021-2022 | |
| Myovant Sciences INC. | $105.71 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $102.24 | 2022-2023 | Seglentis |
| Abbvie INC. | $98.23 | 2024-2025 |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $96.64 | 2023-2024 | Urolift |
| Endo USA, INC. | $95.91 | 2024-2025 | Xiaflex, Aveed |
| Ferring Pharmaceuticals INC. | $93.04 | 2024-2025 | Adstiladrin |
| Dendreon Pharmaceuticals LLC | $78.32 | 2023 | Provenge |
| Becton, Dickinson and Company | $61.92 | 2023-2024 | Bard Urinary Drainage Bag, Bard Tigertail Flexible Tip Ureteral Catheters |
| Procept Biorobotics Corporation | $56.31 | 2025 | |
| Merck Sharp & Dohme LLC | $54.35 | 2022-2025 | Welireg, Keytruda |
| Blue Earth Diagnostics | $47.10 | 2021-2023 | |
| Angiodynamics, INC. | $45.17 | 2022 | |
| Calyxo, INC. | $41.08 | 2025 | Cvac Aspiration System |
| Novartis Pharmaceuticals Corporation | $39.90 | 2025 | |
| Stryker Corporation | $37.77 | 2022 | |
| Progenics Pharmaceuticals, INC. | $34.95 | 2023-2024 | Pylarify |
| Azurity Pharmaceuticals, INC. | $31.35 | 2024-2025 | Azmiro |
| Tempus Ai, INC | $31.10 | 2024 | |
| Sun Pharmaceutical Industries INC. | $30.84 | 2022 | |
| Novo Nordisk INC | $29.42 | 2025 | |
| Verity Pharmaceuticals INC. | $28.31 | 2025 | Trelstar |
| Tolmar, INC. | $22.08 | 2024 | |
| Convatec INC. | $19.43 | 2023 | |
| Valencia Technologies Corporation | $17.61 | 2025 | Ecoin Device Kit |
| Antares Pharma, INC. | $17.21 | 2022 | |
| Olympus America INC. | $16.34 | 2024 | Itind System |
| Clarus Therapeutics INC. | $15.18 | 2021 | |
| Photocure INC | $13.58 | 2022 | |
| Allegis Pharmaceuticals, LLC | $10.05 | 2023 | Urimar-T Caps |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prabhakar Mithal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.